PATENT CLAIM ANALYSIS

Application Number: 16090385
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "326000"]

Abstract:
The present invention relates to piperidinylalkylamide derivatives having dual pharmacological activity towards both the sigma (σ) receptor and the μ-opioid receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.

Claim (Index 27):
The compound according to  claim 13 , wherein the compound of Formula (I) is a compound of Formula (I 6 \u2032) wherein R 7  and R 7\u2032  are independently selected from hydrogen, halogen, \u2014R 6 , \u2014OR 6 , \u2014NO 2 , \u2014NR 6 R 6\u2032\u2033 , NR 6 C(O)R 6\u2032 , \u2014NR 6 S(O) 2 R 6\u2032 , \u2014S(O) 2 NR 6 R 6\u2032 , \u2014NR 6 C(O)NR 6\u2032 R 6\u2033 , \u2014SR 6 , \u2014S(O)R 6 , S(O) 2 R 6 , \u2014CN, haloalkyl, haloalkoxy, \u2014C(O)OR 6 , \u2014C(O)NR 6 R 6\u2032 , \u2014OCH 2 CH 2 OH, \u2014NR 6 S(O) 2 NR 6\u2032 R 6\u2033  and \u2014C(CH 3 ) 2 OR 6 ; and R 6 , R 6\u2032 , R 6\u2033 , R 6\u2032\u2033 , X and n are as defined in claim  1 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.325
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16090403', '15746877', '15747220', '15531810', '15571352']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.812455590719861
- 35 USC 102 Novelty (BERT): 0.5718237659455131
- Combined Prediction Score: 0.7883924082424262
- Mean Citation Score: 445.959034
- Max Citation Score: 473.35364
- Similarity Product: 352.17274652901887

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test